Titolo | Pubblicato in | Anno |
---|---|---|
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study | JOURNAL OF NEUROLOGY | 2018 |
The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study | MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2017 |
The use of immunosuppressant therapy for multiple sclerosis in Italy: A multicenter retroprospective study | PLOS ONE | 2016 |
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma